首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR IMPROVING OR TREATING MUSCLE ATROPHY COMPRISING CULTURE MEDIUM OF STEM CELLS DERIVED FROM MAMMAL UMBILICAL CORDS

PHARMACEUTICAL COMPOSITION FOR IMPROVING OR TREATING MUSCLE ATROPHY COMPRISING CULTURE MEDIUM OF STEM CELLS DERIVED FROM MAMMAL UMBILICAL CORDS

机译:用于改善或治疗包含哺乳动物脐带血干细胞的培养培养基的肌肉萎缩的药物组合物

摘要

The present invention relates to a pharmaceutical composition for preventing or treating muscle atrophy comprising a culture medium of stem cells derived from mammal umbilical cords. When administering the culture medium of stem cells derived from umbilical cords into the muscle, the administered stem cells proliferate the muscular cells at the administration site, increase the amount of muscle, restore muscular fatigue rapidly, and thus are effective for preventing or treating muscle atrophy. Since the pharmaceutical composition according to the present invention uses a culture medium of stem cells, it can overcome technological and practical limitations of therapies using stem cells and has an advantage of easy availability, and thus is significantly effective for preventing and treating muscle atrophy.;COPYRIGHT KIPO 2016
机译:本发明涉及用于预防或治疗肌肉萎缩的药物组合物,该药物组合物包含来源于哺乳动物脐带的干细胞的培养基。当将源自脐带的干细胞的培养基给予肌肉时,所给予的干细胞在给药部位使肌细胞增生,增加肌肉量,迅速恢复肌肉疲劳,因此对于预防或治疗肌肉萎缩有效。 。由于本发明的药物组合物使用干细胞的培养基,因此它可以克服使用干细胞进行治疗的技术和实践上的局限性,并且具有易于获得的优点,因此对于预防和治疗肌肉萎缩非常有效。版权KIPO 2016

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号